CDD-1274
CDD-1274 is an ERα (Estrogen receptor α) variant inhibitor. CDD-1274 induces proteasomal degradation of ERα variants in breast cancer cell lines and causes Y537S ERα degradation. CDD-1274 potently blocks ligand-dependent and ligand-independent ER signaling in endocrine-resistant breast cancer cells. CDD-1274 can be used for the study of breast cancer[1].
Product Specifications
UNSPSC
12352005
Target
Estrogen Receptor/ERR
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Smiles
O=C(NC)CCOCCC(N1CC(C2NCC3=CC(C4=CC(O)=CC=C4OC(F)(F)F)=CC=C3F)CCC2C1)=O
Molecular Formula
C28H33F4N3O5
Molecular Weight
567.57
References & Citations
[1]Devakrishnan AK, et al. Discovery of a novel small molecule degrader of wild type and mutant estrogen receptors using DNA encoded libraries. NPJ Breast Cancer. 2025 Nov 12;11 (1) :125.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ERα
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E2261-41E3-AP 100 µL
EMR1 (EGF-like Module Containing Mucin-like Hormone Receptor-like 1, EMR1 Hormone Receptor, Cell Surface Glycoprotein EMR1, Cell Surface Glycoprotein F4/80, DD7A5-7, EGF-TM7, F4/80, Gpf480, Lymphocyte Antigen 71, Ly71, TM7LN3) (AP) discontinued
Sign In for Pricing
View Details ![IL-2Rα/CD25 Antibody [H7D24]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)